PALLAS 311 nm UVB laser treatment for vitiligo, psoriasis, alopecia areata, and atopic dermatitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective clinical evaluation of the CE-marked PALLAS 311 nm solid-state UVB laser used on skin areas such as the face, hands, arms, feet, or legs. Adult patients with skin conditions expected to respond to targeted UVB will receive two approximately 10-minute laser sessions per week for up to three months, with photographic documentation at baseline and monthly. Investigators will record clinical responses and patients will complete a Patient Satisfaction Scale at study end, while also providing feedback on the device's user-friendliness. The study excludes minors, pregnant people, those with epilepsy, active infection or fever, and participants currently in other trials.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. The subject understands the information provided, gives informed consent to participate in the study and is deemed by the investigator to be able to participate,
2. a skin condition that is expected to respond well to targeted UVB treatment,
3. a signed consent form.

Exclusion Criteria:

1. Patient under 18 years of age,
2. pregnancy
3. epilepsy,
4. fever, infectious diseases,
5. the patient is within one month or currently enrolled in another clinical trial.

Where it's running

• University of Szeged, Albert Szent-Györgyi Clinical Centre, Department of Dermatology and Allergology
  Szeged, Csongrád-Csanád Vármegye, Hungary Recruiting

Study contacts

• Study coordinator: Lajos Kemény, professor, MD, DSc, MHAS
• Email: kemeny.lajos@med.u-szeged.hu
• Phone: +36305152884

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding the factors influencing chronic inflammatory skin diseases

  This study is trying to understand what causes different types of chronic skin conditions, like eczema and psoriasis, to behave differently in patients over time.

  Recruiting University Hospital Schleswig-Holstein · Kiel · NCT05928169

• Abrocitinib for eczema and patchy hair loss in people with Down syndrome

  This trial will test whether taking abrocitinib daily can help improve eczema or patchy hair loss in people with Down syndrome aged 12 and up.

  Recruiting Phase 2 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07242638

• New ceramide‑and‑coconut‑oil skin barrier cream versus petrolatum for dry or irritated skin

  This study will test whether a new ceramide- and coconut oil–based cream can improve skin hydration and reduce dryness and itch in adults with mild to moderate psoriasis, atopic dermatitis, contact dermatitis, or xerosis.

  Recruiting Makati Medical Center · Makati City, National Capital Region · NCT07183423

• Evaluating full-body imaging technology for skin disease detection

  This study is testing a new full-body imaging technology to see if it can help doctors better detect and monitor skin diseases like skin cancer and eczema.

  Recruiting at 3 sites HJN Sverige AB/Neko Health · Stockholm and 2 other locations · NCT06989216

• Public reactions to facial psoriasis, atopic dermatitis, vitiligo, and alopecia areata

  This project tests how adults in the general population emotionally and socially respond to faces showing psoriasis, atopic dermatitis, vitiligo, or alopecia areata.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma, Italia · NCT06801821

• Biomarkers that predict how skin-disease treatments will work

  Researchers are testing blood and skin markers to see if they can forecast which patients with inflammatory skin diseases will respond to systemic treatments over a year.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06599411

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.